Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Global Oncology Milestone 2026

Bishal Gyawali

比沙尔·贾瓦利

MD, PhD

🏢Queen's University(女王大学)🌐Canada

Associate Professor, Department of Oncology and Department of Public Health Sciences; Research Director, Program in Evidence-Based Care肿瘤学与公共卫生科学副教授;循证护理项目研究主任

48
h-index
1
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

The most influential voice of a generation on cancer drug evidence standards and approval rigor. His systematic analyses revealed that the majority of FDA-approved oncology drugs lack overall survival evidence and exposed surrogate endpoint failures in global oncology, prompting regulatory reflection at the FDA, EMA, and Health Canada while amplifying voices from Nepal and the Global South in shaping evidence standards.

Share:

🧪Research Fields 研究领域

Cancer Drug Approval Rigor癌症药物审批严谨性
Clinical Trial Methodology临床试验方法学
Global Oncology全球肿瘤学
Cancer Policy癌症政策
Evidence-Based Oncology循证肿瘤学

🎓Key Contributions 主要贡献

Cancer Drug Approval Evidence Analysis

Demonstrated through landmark systematic reviews that over 70% of FDA cancer drug approvals between 2008 and 2022 were based on surrogate endpoints never validated to predict overall survival benefit, generating regulatory debate and inspiring new FDA guidance on endpoint standards.

Global South Perspective on Oncology Evidence

Championed the principle that cancer drug evidence must be evaluated for applicability in LMIC settings, showing that most drugs approved using surrogate endpoints in high-income countries offer limited value when cost, access, and quality of life are incorporated in LMIC contexts.

Representative Works 代表性著作

[1]

Oncology Drug Approvals: Does Approval Indicate Value?

JAMA Internal Medicine (2019)

Widely cited analysis showing the proportion of FDA oncology approvals lacking overall survival evidence and questioning the translation of surrogate endpoint gains into meaningful patient benefit.

🏆Awards & Recognition 奖项与荣誉

🏆ASCO Conquer Cancer Foundation Merit Award
🏆BMJ Award for Critical Appraisal in Oncology
🏆Nepal Medical Association Distinguished Scientist Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 比沙尔·贾瓦利 的研究动态

Follow Bishal Gyawali's research updates

留下邮箱,当我们发布与 Bishal Gyawali(Queen's University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment